featured
Effect of P2Y12 Inhibitors on Survival Free of Organ Support in Non-Critical Hospitalized Patients With COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial
JAMA 2022 Jan 18;327(3)227-236, JS Berger, LZ Kornblith, MN Gong, HR Reynolds, M Cushman, Y Cheng, BJ McVerry, KS Kim, RD Lopes, B Atassi, S Berry, G Bochicchio, M de Oliveira Antunes, ME Farkouh, Y Greenstein, EM Hade, K Hudock, R Hyzy, P Khatri, A Kindzelski, BA Kirwan, L Baumann Kreuziger, PR Lawler, E Leifer, J Lopez-Sendon Moreno, J Lopez-Sendon, JF Luther, L Nigro Maia, J Quigley, R Sherwin, L Wahid, J Wilson, JS Hochman, MD NealFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.